A double blind, randomised, placebo controlled, multicentre trial of anti-tumour necrotising factor alpha (anti-TNF alpha) chimeric monoclonal antibody (infliximab, Remicade) in combination with methotrexate in patients with very early inflammatory arthritis
Phase of Trial: Phase II/III
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Infliximab (Primary) ; Methotrexate
- Indications Arthritis
- Focus Therapeutic Use
- Acronyms DINORA
- 17 Jun 2017 Results (n=90) presented at the 18th Annual Congress of the European League Against Rheumatism
- 06 Nov 2010 Additional trial investigator (Scott DL) added as reported by United Kingdom Clinical Research Network record.
- 23 Sep 2010 Planned end date changed from 15 Sep 2011 to 1 Jul 2012 as reported by United Kingdom Clinical Research Network record.